Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

The Medicines Company (Hemostasis Portfolio)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of medicine products. The company contains a portfolio of three hemostasis products namely Recothrom Thrombin topical, PreveLeak and Raplixa in Parsippany, New Jersey.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 8 Sylvan Way
  • Parsippany, NJ 07054
  • United States

The Medicines Company (Hemostasis Portfolio) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore The Medicines Company (Hemostasis Portfolio)‘s full profile, request access.

Request full access to PitchBook

The Medicines Company (Hemostasis Portfolio) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore The Medicines Company (Hemostasis Portfolio)‘s full profile, request access.

Request full access to PitchBook